Eli Lilly and Given New $60.00 Price Target at Morgan Stanley

Home › Eli Lilly and Given New $60.00 Price Target at Morgan Stanley

Morgan Stanley's price objective would suggest a potential downside of 1.12% from the stock's previous close.

27.11	Washington Corner \| November 2024
27.11	Pork Checkoff continues building a bigger appetite for pork
27.11	Terminal crossbreeding: A missed opportunity
27.11	Feedlot Forum 2025 features Cattle feeding in a changing environment
27.11	Smithfield Foods continues support for Mayflower Marathon Holiday Food Drive
27.11	Researchers turn to AI to optimize hog selling
27.11	H5N1 in pigs: Where are the knowledge gaps?
26.11	New swine respiratory disease treatment flexibility from nursery to finish
Agriculture and Forestry »

je.st